Gastroesophageal Junction (GEJ) Cancers
1 clinical trials · Condition
◉ Watch Gastroesophageal Junction (GEJ) Cancers
| Record | Firm | Date |
|---|---|---|
| Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer (NCT04847466) | National Cancer Institute (NCI) | 2021-12-14 |
Track Gastroesophageal Junction (GEJ) Cancers automatically
Every clearance here is in the API, with alerts when new ones post.